Atomoxetine is a non-stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adults [1]. It is a selective norepinephrine reuptake inhibitor (SNRI) [1].
How does Atomoxetine work for ADHD?
Atomoxetine works by increasing the levels of norepinephrine, a neurotransmitter that plays a role in attention and impulse control, in the brain [1]. Unlike stimulant medications, it does not affect dopamine levels and is not considered a controlled substance [1].
What are the potential side effects of Atomoxetine?
Common side effects associated with atomoxetine include stomach upset, decreased appetite, nausea, vomiting, fatigue, dizziness, and mood swings [2]. Less common but more serious side effects can include liver problems, suicidal thoughts, and cardiovascular issues like increased blood pressure and heart rate [2]. Patients and caregivers should monitor for any changes in mood, behavior, or physical symptoms [2].
When does the patent for Atomoxetine expire?
Information regarding specific patent expiry dates for atomoxetine can be found on resources like DrugPatentWatch.com [3]. These dates are crucial for determining when generic versions of the medication may become available [3].
Can generic Atomoxetine be made before patent expiry?
Generally, generic versions of a medication cannot be manufactured and marketed until the relevant patents and exclusivities have expired [3]. The exact timeline for generic entry depends on the specific patent landscape and any potential legal challenges [3].
Who makes Atomoxetine?
Atomoxetine was originally developed by Eli Lilly and Company and is marketed under the brand name Strattera [1]. Following patent expirations, other pharmaceutical companies may produce generic versions of the medication.
How does Atomoxetine compare to other ADHD medications?
Atomoxetine offers an alternative to stimulant medications, which are often the first-line treatment for ADHD. It may be a suitable option for individuals who do not respond well to stimulants, experience significant side effects from them, or have co-existing conditions that make stimulant use inadvisable [1].
What are the risks of Atomoxetine treatment?
While generally considered safe and effective for many, atomoxetine carries risks, including potential liver damage, increased blood pressure, and, rarely, suicidal ideation, particularly in children and adolescents [2]. Regular monitoring by a healthcare professional is essential to manage these risks [2].
What is the typical dosage and administration of Atomoxetine?
Dosage for atomoxetine is typically individualized based on the patient's weight and response to treatment [1]. It is usually taken once or twice daily, with or without food [1].
---
Sources:
1. https://www.drugpatentwatch.com/atomoxetine-medication
2. https://www.drugpatentwatch.com/atomoxetine-side-effects
3. https://www.drugpatentwatch.com/atomoxetine-patent-expiration